[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.43.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
August 16, 2000

Transplant Therapy for Diabetes

JAMA. 2000;284(7):822. doi:10.1001/jama.284.7.822

Ten research centers in North America and Europe will attempt to replicate the recent success of an experimental technique for transplanting insulin-producing islet cells into patients with type 1 diabetes, the National Institutes of Health (NIH) announced last month.

Starting this fall, the Immune Tolerance Network (ITN), an international consortium of clinical researchers who are seeking ways to induce immune tolerance (as in tolerance of the transplanted islet cells), will expand studies of the new technique, known as the "Edmonton protocol." About 40 patients with poorly controlled type 1 diabetes and secondary complications of the disease will receive islet cell transplants.

First Page Preview View Large
First page PDF preview
First page PDF preview
×